Navigation Links
Bioheart Founder, Howard J. Leonhardt, Becomes Chairman of the Board of Directors
Date:3/17/2008

Therapy, an autologous, adipose cell treatment for acute heart damage, and MyoCell II with SDF-1(TM), a therapy utilizing autologous cells genetically modified to express additional growth factors. The company holds rights to more than 100 related patents and patents pending.

MyoCell and MyoCell II with SDF-1 are registered trademarks of Bioheart, Inc.

Forward-Looking Statements:

Except for historical matters contained herein, statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Without limiting the generality of the foregoing, words such as "may," "will," "to," "plan," "expect," "believe," "anticipate," "intend," "could," "would," "estimate," or "continue" or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements.

Investors and others are cautioned that a variety of factors, including certain risks, may affect our business and cause actual results to differ materially from those set forth in the forward-looking statements. These risk factors include, without limitation, (i) our ability to secure additional financing; (ii) the timely success and completion of our clinical trials; (iii) the occurrence of any unacceptable side effects during or after preclinical and clinical testing of our product candidates; (iv) regulatory approval of our product candidates; (v) our dependence on the success of our lead product candidate; (vi) our inability to predict the extent of our future losses or if or when we will become profitable; (vii) our ability to protect our intellectual property rights; (viii) our inability to predict the extent of our future losses or if or when we will become profitable; and (ix) intense competition. The company is also subject to the risks and uncertainties described in its filings with the Securities and Exchange Commission, including Post-Effectiv
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Quintiles Completes Previously Announced New Investor Partnership, Co-Led by Founder, Chairman and CEO Dennis Gillings, Bain Capital, TPG and 3i
2. Nektar Therapeutics President and CEO Howard W. Robin to Present At JPMorgan 26th Annual Healthcare Conference
3. VivoMetrics(R) Appoints Howard R. Baker as New President and Chief Executive Officer
4. Nektar Therapeutics President and CEO Howard Robin to Present at 2007 BIO InvestorForum
5. REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide
6. Prof. Michel Klein Becomes Chief Scientific Officer at AMVAC
7. Haemonetics Becomes Preferred Provider of Plasma Collection Products to Octapharma Europe
8. BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy
9. Pathway Medical Technologies Names Paul Buckman Chairman of the Board of Directors
10. Bristol-Myers Squibb Board Elects James M. Cornelius Chairman of the Board
11. BioSeek Elects Roy Whitfield Executive Chairman of Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... BURNIE, Md. , Aug. 19, 2014 ... clinical research industry, recently announced the formation of the ... pleased to announce the addition of Dr. William ... Photo - http://photos.prnewswire.com/prnh/20140818/136957 The ... across a variety of therapeutic areas and set strategic ...
(Date:8/19/2014)... , Aug. 19, 2014   Synthetic Biologics, ... developing novel anti-infective biologic and drug programs targeting ... announced today that its novel C. difficile ... 54 th Interscience Conference on Antimicrobial Agents ... Washington D.C. Synthetic Biologics, ...
(Date:8/19/2014)... August 19, 2014 Sales Horizons, a ... its online sales skills training course to ... , MedTech clinical staff spend the majority of their ... standalone medical center, or physician practice – providing support ... why stop there? Sales Horizons believes clinical staff are ...
(Date:8/18/2014)... new therapy developed by researchers at the University ... and Columbia University Medical Center (CUMC) may help ... treatment. , The researchers demonstrated in a ... selectively inhibit blood vessel re-narrowing and simultaneously promote ... balloon catheter to open narrowed or blocked arteries. ...
Breaking Biology Technology:CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 2CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 4Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 2Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 3Selective therapy may improve artery repair after interventional cardiovascular procedures 2Selective therapy may improve artery repair after interventional cardiovascular procedures 3
... Kathleen A. Maguire-Zeiss, Brandon K. Harv e y, Rita E. Giuliano and,H ... , Introduction , ... number of factors, including , method ... transfection of mammalian cells has proven to yield ...
... Menu B. Leddy, Biotechnology Research Department,Orange County ... , Introduction ... of bacterial species from membrane , ... of bacterial cells from membrane biofilms cannot be ...
... , Introduction , ... use as primers , or probes in genetic ... traditionally been done by slab gel electrophoresis or HPLC, but these , ... not provide desired quantitative precision or automation. Capillary ...
Cached Biology Technology:Commercial Plasmid Preparation Methods Yield DNA With Different Transfection Capabilities 2Commercial Plasmid Preparation Methods Yield DNA With Different Transfection Capabilities 3Commercial Plasmid Preparation Methods Yield DNA With Different Transfection Capabilities 4Commercial Plasmid Preparation Methods Yield DNA With Different Transfection Capabilities 5Commercial Plasmid Preparation Methods Yield DNA With Different Transfection Capabilities 6Separation of 16S rRNA PCR Products From a Model Community Using Temporal Temperature Gradient Gel Electrophoresis, Rev A 2Separation of 16S rRNA PCR Products From a Model Community Using Temporal Temperature Gradient Gel Electrophoresis, Rev A 3Separation of 16S rRNA PCR Products From a Model Community Using Temporal Temperature Gradient Gel Electrophoresis, Rev A 4Separation of 16S rRNA PCR Products From a Model Community Using Temporal Temperature Gradient Gel Electrophoresis, Rev A 5Separation of 16S rRNA PCR Products From a Model Community Using Temporal Temperature Gradient Gel Electrophoresis, Rev A 6Separation of 16S rRNA PCR Products From a Model Community Using Temporal Temperature Gradient Gel Electrophoresis, Rev A 7Oligonucleotide Purity Analysis by Capillary Electrophoresis 2Oligonucleotide Purity Analysis by Capillary Electrophoresis 3
(Date:8/20/2014)... screening outcomes of approximately 3 million infants, a team ... the University of Massachusetts Medical School, have shown that ... successfully implemented across public health newborn screening programs. Data ... 20 issue of the Journal of the American ... of SCID in newborns is higher than previously thought ...
(Date:8/20/2014)... that acral melanomas the rare type of skin cancer ... distinct from other more common types of skin cancer, according ... Pigment Cell & Melanoma Research . , Acral melanoma ... the feet, nail-beds and other hairless parts of the skin. ... by UV damage from the sun. , The team, from ...
(Date:8/20/2014)... into a chili pepper causes a burning spiciness that ... exploring the chili pepper,s effect are using their findings ... of pain, which can be caused by inflammation or ... which is being tested in clinical trials, in ACS, ... and colleagues explain that decades ago, scientists had pegged ...
Breaking Biology News(10 mins):Newborn screening expansion offers early diagnosis and treatment to infants with SCID 2Newborn screening expansion offers early diagnosis and treatment to infants with SCID 3Scientists learn more about rare skin cancer that killed Bob Marley 2
... after the world,s first ultrasonic detection device invented ... Virginia Tech Carilion Research Institute scientists have ... have long suspected: ultrasound applied to the periphery, such ... to the brain. And that,s just the ...
... ship is at anchor for longer periods algae, shells and ... economic losses of billions of Dollar. Biological growth on the ... the hull below the waterline which has a braking effect ... basified bio layer, the consumption of fuel can increase by ...
... a simple "drag-and-drop" computer interface and DNA self-assembly ... drug development that could drastically reduce the time ... work supported by a National Science Foundation (NSF) ... NanoLabs of Reston, Va., recently developed and began ...
Cached Biology News:Neuroscientists prove ultrasound can be tweaked to stimulate different sensations 2Neuroscientists prove ultrasound can be tweaked to stimulate different sensations 3Keeping ship hulls free of marine organisms 2Drag-and-drop DNA 2Drag-and-drop DNA 3Drag-and-drop DNA 4
... This DuoSet ELISA Development kit contains the ... sandwich ELISAs to measure natural and recombinant ... and serum. Each kit contains sufficient materials ... plates, provided that the following conditions are ...
Blimp-1 (H-150)...
Mouse Galectin-1 Affinity Purified Polyclonal Ab...
PSGL-1 (215)...
Biology Products: